Third Rock funds gene therapy startup Voyager with $45m
The early-stage biotechnology funder Third Rock Ventures reinforced its belief that gene therapy is an idea whose time has come by investing $45m in the startup Voyager Therapeutics.
The early-stage biotechnology funder Third Rock Ventures reinforced its belief that gene therapy is an idea whose time has come by investing $45m in the startup Voyager Therapeutics.